7-French Factor: Absence Of Fidelis Lead Gives St. Jude’s Riata A Boost

Medtronic's recall of its Sprint Fidelis ICD leads will have only a small impact on overall implantable defibrillator demand, but the market leader's share will suffer as doctors seek the thinnest leads available, electrophysiologists suggested on an Oct. 29 conference call

More from Archive

More from Medtech Insight